STOCK TITAN

Vuzix M400 Smart Glasses Begin Use Case in Japan for Ambulance Emergency Medical Care

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Vuzix Corporation (NASDAQ: VUZI) announced its M400 smart glasses are being trialed in Japan for emergency medical care, aiming to enhance patient outcomes during transport. Collaborating with Juntendo University and Shizuoka Hospital, EMTs use the glasses for real-time communication of vital signs and ECG data to hospital staff, allowing for quicker diagnoses and treatment decisions. Initially implemented by the Shunto Izu Fire Department, the trial may expand to additional ambulances, showcasing Vuzix's innovative healthcare applications.

Positive
  • Implementation of M400 smart glasses for real-time medical communication enhances emergency care.
  • Collaboration with reputable institutions such as Juntendo University and Shizuoka Hospital.
  • Potential for expanded use in more ambulances, increasing market presence.
Negative
  • None.

Goal is to provide early treatment and improve outcomes for transported emergency patients

ROCHESTER, N.Y., Aug. 16, 2022  Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced that its M400 smart glasses are currently being trialed in Japan for an emergency medical care plan with the objective of providing early treatment in an effort to improve patient outcomes and lifesaving rates for critically ill patients undergoing transport to the hospital. The collaborative effort on this trial involves Juntendo University, Shizuoka Hospital, the Shunto Izu Fire Department, and AVR Japan Co., Ltd.

In this trial, emergency medical technicians (EMTs) are using Vuzix M400 smart glasses to convey medical information from the ambulance to the hospital from the moment of patient engagement to their delivery to the hospital. Previously, the only means of communication between rescuers and doctors waiting in the hospital was via mobile phone calls, and information sharing was only vocal. By using smart glasses with two-way audio and video communications, it becomes possible to share medical information such as vital signs and ECG readouts, as well as the patient's facial expressions and other visual changes in condition, in real time to doctors and nurses who are on standby at the hospital to which they are being transported.

By sharing this information in real time with the hospital, it is expected that examinations, diagnoses, and preliminary medical treatment decisions can be made by various departments in the hospital before the patient even arrives. Additionally, in-hospital doctors can better instruct accurate in-transit emergency treatment (blood transfusion, surgery, thrombolytic therapy, intravascular treatment, etc.) for time-critical illnesses such as cardiovascular diseases.

Currently, Vuzix smart glasses are being used by select ambulances under the jurisdiction of the Shunto Izu Fire Department. In the future, there are plans to expand the trial to include more ambulances to provide further research on the effectiveness of smart glasses usage.

"Among their expanding healthcare uses, Vuzix smart glasses can be an important life-saving tool for EMTs that require critical interaction and support from the hospitals to which they ae headed," said Paul Travers, President and Chief Executive Officer at Vuzix. "Our glasses are lightweight, comfortable and completely wireless, making them ideal to be used alongside the other head-mounted equipment EMTs must wear. We look forward to seeing an expansion of this trial by its participants, as well as adoption for similar usage by other providers in Japan and around the world."

About Vuzix Corporation

Vuzix is a leading supplier of Smart Glasses and Augmented Reality (AR) technologies and products for the consumer and enterprise markets. The Company's products include personal display and wearable computing devices that offer users a portable high-quality viewing experience, provide solutions for mobility, wearable displays and augmented reality. Vuzix holds 247 patents and patents pending and numerous IP licenses in the Video Eyewear field. The Company has won Consumer Electronics Show (or CES) awards for innovation for the years 2005 to 2022 and several wireless technology innovation awards, among others. Founded in 1997, Vuzix is a public company (NASDAQ: VUZI) with offices in Rochester, NY, Oxford, UK, and Tokyo, Japan.  For more information, visit the Vuzix website,  Twitter and Facebook pages.

Forward-Looking Statements Disclaimer

Certain statements contained in this news release are "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. Forward-looking statements contained in this release relate to Vuzix Smart Glasses, ongoing certifications of this use case, our current and future business relationships and opportunities with Juntendo University, Shizuoka Hospital, the Shunto Izu Fire Department, and AVR Japan, and among other things the Company's leadership in the Smart Glasses and AR display industry. They are generally identified by words such as "believes," "may," "expects," "anticipates," "should" and similar expressions. Readers should not place undue reliance on such forward-looking statements, which are based upon the Company's beliefs and assumptions as of the date of this release. The Company's actual results could differ materially due to risk factors and other items described in more detail in the "Risk Factors" section of the Company's Annual Reports and MD&A filed with the United States Securities and Exchange Commission and applicable Canadian securities regulators (copies of which may be obtained at www.sedar.com or www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. The Company specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.

Media and Investor Relations Contact:

Ed McGregor, Director of Investor Relations 
Vuzix Corporation 
ed_mcgregor@vuzix.com  
Tel: (585) 359-5985

Vuzix Corporation, 25 Hendrix Road, West Henrietta, NY 14586 USA, 
Investor Information – IR@vuzix.com  www.vuzix.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/vuzix-m400-smart-glasses-begin-use-case-in-japan-for-ambulance-emergency-medical-care-301606866.html

SOURCE Vuzix Corporation

FAQ

What is the purpose of the Vuzix M400 smart glasses trial in Japan?

The trial aims to improve emergency medical care by enabling real-time communication of patient data between EMTs and hospital staff.

Which institutions are collaborating on the Vuzix smart glasses trial?

The trial involves Juntendo University, Shizuoka Hospital, the Shunto Izu Fire Department, and AVR Japan Co., Ltd.

What benefits do Vuzix smart glasses provide to emergency medical technicians?

They enable the sharing of vital signs, ECG data, and visual changes in real-time, enhancing patient treatment during transport.

How could the Vuzix smart glasses trial impact the company's stock (VUZI)?

Successful trials may enhance Vuzix's reputation and market position in the healthcare sector, potentially positively affecting stock performance.

When was the press release regarding Vuzix smart glasses released?

The press release was issued on August 16, 2022.

Vuzix Corporation

NASDAQ:VUZI

VUZI Rankings

VUZI Latest News

VUZI Stock Data

312.13M
60.79M
17.42%
13.64%
14.99%
Consumer Electronics
Radio & Tv Broadcasting & Communications Equipment
Link
United States of America
WEST HENRIETTA